CBIS/FSO NAC Makes Headway with American States University

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
34
CBIS/FSO NAC Makes Headway with American States University 250-Acre Industrial Hemp Project with Major Purchase Interests from Ministry of Health, Medical Practitioners, and Other Significant Groups Representing Vast Community Economic Growth

IRVINE, CA--(Marketwired - Oct 5, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC) are pleased to report that the American States University Department of Agriculture industrial hemp research project on the San Joaquin Sovereign Tribal Fee Land is making good progress. There have been several property visits from the Ministry of Health of a certain Country in need of cannabinoids, stating "international supply deficiencies of high-quality industrial hemp for proper research." The government Ministry of Health entity is one of several groups that have expressed serious interests to purchase the entire crop.

Another example, a private medical practitioner group consisting of several doctors and very large medical services agent group came to see the research project looking to treat and supply a vast range of medical patients requiring a large amount of cannabinoids, and again, the discussion was the opportunity to purchase the crop in full.

"This intense growing demand is the reason we are doing this, we can undoubtedly provide a large amount of cannabinoids for such large medical research projects for critical ailments, however, our research, no matter how large, will only touch the tip of the iceberg of need. This strongly underlines the disparity between the lack of supply and the rising demand for cannabinoids as evidenced in the Nevada shortage this year as well as other indicating factors of serious concern," stated Mr. Raymond C. Dabney, President & CEO, Co-Founder, Cannabis Science Inc.

The lack of high-quality industrial hemp represents enormous potential for economic growth for the community and surrounding areas, as well as the University, its Partners, and Cannabis Science. Nevertheless, one of the priorities of the harvest is to ensure that sufficient crop remains to produce cannabinoids for our industrial research for critical ailments, research work into the development of paper, biodegradable fuel, clothing materials, and building materials designed to induce prospective financial prosperity for the local surrounding areas by creating new revenue streams for a diverse industrial hemp-based market.

The American States University Department of Agriculture Program is increasing its employment of locals from the surrounding community to meet the labor-intensive requirements of harvesting the initial industrial hemp acreages at its optimum, with the newest harvesting schedule is set for maximum cannabinoid production. The American States University partners have worked closely with CBIS/FSO NAC and have shared responsibility and oversight of this Native American economic development initiative.

The Company has defined how the Universities will provide an affordable opportunity to acquire a quality education and how this education will form the basis for economic development. As an integral part of each land package deal with CBIS/FSO NAC, the University partners expect to provide vertically-integrated operations to provide jobs throughout the community, full scholarships and additionally-subsidized education packages to members of the Native American community and any other challenged individuals with the desire to improve their job skills based on American States and RCDU University packages introduced to their community.

About Cannabis Science, Inc.

Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to several illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

 Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission.

Cannabis Science, Inc. Dr. Allen Herman Chief Medical Officer (CMO) allen.herman@cannabisscience.com Tel: 1-888-263-0832 Cannabis Science, Inc. Mr. Raymond C. Dabney President & CEO, Co-Founder raymond.dabney@cannabisscience.com Tel: 1-888-263-0832

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 150

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 136

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 176

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 161

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 191

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Alliance Between Vireo and Curio Enhances Growth Opportunities

Updated Category News Views 201

Strategic Partnership Announced Leading cannabis companies Vireo Growth Inc. and Curio Wellness have forged a partnership aimed at leveraging shared resources to tap into the burgeoning cannabis market. This collaboration marks an exciting new chapter for both companies as they work to introduce innovative health and wellness products to consumers. Vireo Growth Inc.: A...

Continue Reading
G42 and Mistral AI Collaborate for Innovative AI Solutions

Updated Category News Views 251

Strategic Partnership between G42 and Mistral AI In a significant development for global artificial intelligence, G42, a technology group based in Abu Dhabi, has teamed up with Mistral AI, a reputable AI company headquartered in Paris. This partnership was announced during the Choose France event and stands as a testament to the collaborative spirit between the UAE and...

Continue Reading
Trellus Marketplace Launches: A New Era for Local Shopping

Updated Category News Views 303

Launch of Trellus Marketplace Revolutionizes Local Shopping Trellus Marketplace has made a significant entrance into the e-commerce world, becoming the first platform entirely dedicated to the unique offerings of Long Island's small businesses. This innovative online marketplace allows consumers to shop for local goods directly from their desktops, iOS, and Android...

Continue Reading
Gunderson Dettmer Expands Leadership with New Chief Revenue Officer

Updated Category News Views 275

Gunderson Dettmer Welcomes Erin Stone Dimry Gunderson Dettmer is thrilled to announce the appointment of Erin Stone Dimry as the Chief Revenue Officer. As a global leader in the innovation economy, the firm recognizes the importance of strategic leadership for its continued growth and success. Significance of Erin's Role In her new position, Erin will collaborate closely...

Continue Reading
Newly Approved Services by AB Ignitis Gamyba Benefit Consumers

Updated Category News Views 203

Introduction to the New Regulations AB “Ignitis grup?” has announced a significant development regarding the services provided by its subsidiary, AB “Ignitis gamyba.” The National Energy Regulatory Council (NERC) has recently approved a resolution aimed at amending previous regulations pertaining to the methodology for calculating electricity prices and other...

Continue Reading